Phibro Animal Health Corporation (NASDAQ:PAHC) Given Consensus Recommendation of "Reduce" by Brokerages

Key Points

• Phibro Animal Health Corporation has received a consensus recommendation of "Reduce" from analysts, with an average price target of $24.40.
• The stock is currently down 2.0%, trading at $26.59, with a twelve-month low of $16.16 and high of $31.80.
• The company recently announced a quarterly dividend of $0.12 per share, representing a 1.8% yield and a dividend payout ratio of 61.54%.

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) have earned a consensus rating of "Reduce" from the six research firms that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $24.40.

A number of research analysts have commented on the company. BNP Paribas upgraded Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. JPMorgan Chase & Co. upgraded Phibro Animal Health from a "neutral" rating to an "overweight" rating and increased their price objective for the company from $25.00 to $35.00 in a research report on Monday, July 7th. Wall Street Zen upgraded Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Morgan Stanley set a $26.00 price target on Phibro Animal Health and gave the stock an "equal weight" rating in a research report on Wednesday, June 25th. Finally, BNP Paribas Exane upgraded Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target on the stock in a research report on Monday, June 16th.

Institutional Trading of Phibro Animal Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. Financial Management Professionals Inc. acquired a new stake in shares of Phibro Animal Health in the second quarter valued at about $32,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Phibro Animal Health in the fourth quarter valued at about $29,000. National Bank of Canada FI acquired a new stake in shares of Phibro Animal Health in the first quarter valued at about $30,000. Lazard Asset Management LLC grew its holdings in Phibro Animal Health by 2,739.7% during the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after purchasing an additional 1,589 shares during the period. Finally, Virtus Fund Advisers LLC bought a new position in Phibro Animal Health during the fourth quarter worth about $69,000. Institutional investors and hedge funds own 99.34% of the company's stock.

Phibro Animal Health Price Performance

Shares of PAHC traded up $0.90 during mid-day trading on Tuesday, reaching $28.23. The company had a trading volume of 122,006 shares, compared to its average volume of 257,750. Phibro Animal Health has a twelve month low of $16.16 and a twelve month high of $31.80. The company has a debt-to-equity ratio of 2.67, a current ratio of 2.91 and a quick ratio of 1.23. The company's 50-day moving average is $26.91 and its 200-day moving average is $23.45. The company has a market capitalization of $1.14 billion, a P/E ratio of 36.18, a P/E/G ratio of 0.44 and a beta of 0.80.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, beating analysts' consensus estimates of $0.52 by $0.11. Phibro Animal Health had a return on equity of 30.51% and a net margin of 2.68%. The firm had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. On average, equities analysts anticipate that Phibro Animal Health will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 24th. Investors of record on Wednesday, September 3rd will be given a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, September 3rd. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.7%. Phibro Animal Health's payout ratio is currently 61.54%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.